Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| (NASDAQ: GPCR) | Delayed: 27.05 -0.42 (1.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.47 | 52 Week High | $ | |||
| Open | $27.14 | 52 Week Low | $ | |||
| Day High | $28.05 | P/E | N/A | |||
| Day Low | $26.38 | EPS | $ | |||
| Volume | 629,339 | |||||
| VEEVA SYSTEMS, Inc. (NYSE: VEEV) | Delayed: 285.04 +1.54 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $283.50 | 52 Week High | $42.58 | |||
| Open | $284.23 | 52 Week Low | $19.97 | |||
| Day High | $286.98 | P/E | 9,501.33 | |||
| Day Low | $279.80 | EPS | $0.03 | |||
| Volume | 440,065 | |||||
